Immunogenic oncolysis by tigilanol tiglate
Tigilanol tiglate is an oncolytic small molecule that is undergoing clinical trials. A recent study revealed the capacity of this pyroptosis inducer to elicit hallmarks of immunogenic cell death. In addition, intratumoral injection of tigilanol tiglate can sensitize subcutaneous cancers to subsequen...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2024-12-01
|
| Seri Bilgileri: | OncoImmunology |
| Konular: | |
| Online Erişim: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2360230 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|